Ftse Mib
33.303,93
0,65%
DAX
19.422,05
0,83%
S&P 500
5.998,74
-0,38%
NASDAQ
19.060,48
-0,60%
Bitcoin
95.248,11
-0,76%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pulmonx Corporation (LUNG) Pulmonx Corporation (LUNG) Notizie

LUNG

Pulmonx (LUNG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LUNG
DataOraFonteTitoloSimboloCompagnia
27/11/202400:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
22/11/202422:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
20/11/202422:05GlobeNewswire Inc.Pulmonx to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
19/11/202415:00Business WirePulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and ProvidersNASDAQ:LUNGPulmonx Corporation
15/11/202401:47Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LUNGPulmonx Corporation
07/11/202422:05GlobeNewswire Inc.Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:LUNGPulmonx Corporation
05/11/202422:05GlobeNewswire Inc.Pulmonx to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
01/11/202421:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUNGPulmonx Corporation
30/10/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUNGPulmonx Corporation
30/10/202421:05GlobeNewswire Inc.Pulmonx Reports Third Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
16/10/202422:05GlobeNewswire Inc.Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:LUNGPulmonx Corporation
09/09/202422:05GlobeNewswire Inc.Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024NASDAQ:LUNGPulmonx Corporation
29/08/202422:05GlobeNewswire Inc.Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth ConferenceNASDAQ:LUNGPulmonx Corporation
22/08/202422:05GlobeNewswire Inc.Pulmonx to Present at the 2024 Wells Fargo Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
31/07/202422:05GlobeNewswire Inc.Pulmonx Reports Second Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
29/07/202422:05GlobeNewswire Inc.Pulmonx to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:LUNGPulmonx Corporation
10/07/202422:05GlobeNewswire Inc.Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024NASDAQ:LUNGPulmonx Corporation
31/05/202422:38Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LUNGPulmonx Corporation
06/05/202423:03GlobeNewswire Inc.Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LUNGPulmonx Corporation
01/05/202422:05GlobeNewswire Inc.Pulmonx Reports First Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
10/04/202422:05GlobeNewswire Inc.Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024NASDAQ:LUNGPulmonx Corporation
02/04/202422:05GlobeNewswire Inc.Pulmonx Announces Appointment of Mehul Joshi as Chief Financial OfficerNASDAQ:LUNGPulmonx Corporation
08/03/202402:02Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:LUNGPulmonx Corporation
29/02/202422:31Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LUNGPulmonx Corporation
27/02/202422:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LUNGPulmonx Corporation
27/02/202402:48Business WirePulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal®-System in der CONVERT-II-ZulassungsstudieNASDAQ:LUNGPulmonx Corporation
27/02/202402:40Business WirePulmonx annonce le traitement du premier patient par système AeriSeal® dans l'essai pivot CONVERT IINASDAQ:LUNGPulmonx Corporation
27/02/202402:39Business WirePulmonx annuncia il trattamento del primo paziente con il sistema AeriSeal® nello studio pivotale CONVERT IINASDAQ:LUNGPulmonx Corporation
26/02/202414:00Business WirePulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal TrialNASDAQ:LUNGPulmonx Corporation
21/02/202422:06GlobeNewswire Inc.Pulmonx Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LUNGPulmonx Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LUNG

La tua Cronologia

BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BAMI
Banco BPM
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
NEXI
Nexi S.p.A
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
LDO
Leonardo
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
IVG
Iveco Group NV
BIT
CPR
Davide Campari
BIT
RACE
Ferrari NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network